Strathmore's Who's Who Business Networking

Professional of the Year for 2010 in Cancer Drug Research: Tricia J. Vos, Ph.D.

Member PhotoTricia J. Vos, Ph.D.
IndustryPharmaceutical
TitleSenior Scientist II
ExpertiseOncology, Drug Discovery, Medicinal Chemistry
Current OrganizationMillennium: The Takeda Oncology Company
Type of OrganizationR&D
Major ProductCancer drugs
Area of DistributionNational/International
University/DegreeB.A., Franklin & Marshall College; Ph.D., University of Minnesota
BornJuly 5, 1972
Honors & AwardsPhi Beta Kappa
Published WorksPublications include-"Antitumor Activity of MLN8054, an Orally Small-Molecule Inhibitor of Aurora A Kinase", Manfredi MC, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, Galvin KM, Hoar KM, Huck JJ, LeRoy RJ, Ray ET, Sells TB, Stringer B, Stroud SG, Vos TJ, Weatherhead GS, Wysong DR, Zhang M, Bolen JD, Claiborne CF, Proc. Natl. Acad. Sci. (USA) 2007, 104(10), 4106-4111 and "Identification and Structure-Activity Relationships of a New Series of Melanocortin-4 Receptor Antagonists", Vos TJ, Balani S, Blackburn C, Chau R, Danca MD, Drabic SV, Farrer CA, Patane MA, Stroud SG, Yowe, DL, Claiborne CF, Bioorg. Med. Chem. Lett. 2006, 16, 2302-2305; Patents and Patent Applications include- "Preparation of Pyrazoline Derivatives with Raf Kinase Inhibitory Activity", Adams RS, Duffey M, Gould AE, Greenspan PD, Kulkarni BA, Vos TJ, WO 08/079277; Presentations include- "Small Molecule MC4 Receptor Antagonists", Vos TJ, IBC's Hit to Lead Success Stories Conference, San Diego, CA, 2005
AffiliationsACS
Full biographical and contact details are available to logged in members only.
If you are a member please log in using the form in the header to see more data.
If you are not already member you may Click Here to Register for consideration.